SrasV1, PubMed, Checkpoint, bibRecord, 001226

Aptamer-based therapeutics: new approaches to combat human viral diseases.

Identifieur interne : 001226 ( PubMed/Checkpoint ); précédent : 001225; suivant : 001227

Aptamer-based therapeutics: new approaches to combat human viral diseases.

Auteurs : Ka-To Shum [États-Unis] ; Jiehua Zhou ; John J. Rossi

Source :

Pharmaceuticals (Basel, Switzerland) [ 1424-8247 ] ; 2013.

RBID : pubmed:24287493

Abstract

Viruses replicate inside the cells of an organism and continuously evolve to contend with an ever-changing environment. Many life-threatening diseases, such as AIDS, SARS, hepatitis and some cancers, are caused by viruses. Because viruses have small genome sizes and high mutability, there is currently a lack of and an urgent need for effective treatment for many viral pathogens. One approach that has recently received much attention is aptamer-based therapeutics. Aptamer technology has high target specificity and versatility, i.e., any viral proteins could potentially be targeted. Consequently, new aptamer-based therapeutics have the potential to lead a revolution in the development of anti-infective drugs. Additionally, aptamers can potentially bind any targets and any pathogen that is theoretically amenable to rapid targeting, making aptamers invaluable tools for treating a wide range of diseases. This review will provide a broad, comprehensive overview of viral therapies that use aptamers. The aptamer selection process will be described, followed by an explanation of the potential for treating virus infection by aptamers. Recent progress and prospective use of aptamers against a large variety of human viruses, such as HIV-1, HCV, HBV, SCoV, Rabies virus, HPV, HSV and influenza virus, with particular focus on clinical development of aptamers will also be described. Finally, we will discuss the challenges of advancing antiviral aptamer therapeutics and prospects for future success.

DOI: 10.3390/ph6121507
PubMed: 24287493

Affiliations:

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: 001090
to stream PubMed, to step Curation: 001090

Links to Exploration step

pubmed:24287493

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Aptamer-based therapeutics: new approaches to combat human viral diseases.</title>
<author><name sortKey="Shum, Ka To" sort="Shum, Ka To" uniqKey="Shum K" first="Ka-To" last="Shum">Ka-To Shum</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Molecular and Cellular Biology, Beckman Research Institute of City of Hope, 1500 East Duarte Rd, Duarte, CA 91010, USA. kshum@coh.org.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Molecular and Cellular Biology, Beckman Research Institute of City of Hope, 1500 East Duarte Rd, Duarte, CA 91010</wicri:regionArea>
<placeName><region type="state">Californie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Zhou, Jiehua" sort="Zhou, Jiehua" uniqKey="Zhou J" first="Jiehua" last="Zhou">Jiehua Zhou</name>
</author>
<author><name sortKey="Rossi, John J" sort="Rossi, John J" uniqKey="Rossi J" first="John J" last="Rossi">John J. Rossi</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2013">2013</date>
<idno type="RBID">pubmed:24287493</idno>
<idno type="pmid">24287493</idno>
<idno type="doi">10.3390/ph6121507</idno>
<idno type="wicri:Area/PubMed/Corpus">001090</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001090</idno>
<idno type="wicri:Area/PubMed/Curation">001090</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001090</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001226</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001226</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Aptamer-based therapeutics: new approaches to combat human viral diseases.</title>
<author><name sortKey="Shum, Ka To" sort="Shum, Ka To" uniqKey="Shum K" first="Ka-To" last="Shum">Ka-To Shum</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Molecular and Cellular Biology, Beckman Research Institute of City of Hope, 1500 East Duarte Rd, Duarte, CA 91010, USA. kshum@coh.org.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Molecular and Cellular Biology, Beckman Research Institute of City of Hope, 1500 East Duarte Rd, Duarte, CA 91010</wicri:regionArea>
<placeName><region type="state">Californie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Zhou, Jiehua" sort="Zhou, Jiehua" uniqKey="Zhou J" first="Jiehua" last="Zhou">Jiehua Zhou</name>
</author>
<author><name sortKey="Rossi, John J" sort="Rossi, John J" uniqKey="Rossi J" first="John J" last="Rossi">John J. Rossi</name>
</author>
</analytic>
<series><title level="j">Pharmaceuticals (Basel, Switzerland)</title>
<idno type="ISSN">1424-8247</idno>
<imprint><date when="2013" type="published">2013</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Viruses replicate inside the cells of an organism and continuously evolve to contend with an ever-changing environment. Many life-threatening diseases, such as AIDS, SARS, hepatitis and some cancers, are caused by viruses. Because viruses have small genome sizes and high mutability, there is currently a lack of and an urgent need for effective treatment for many viral pathogens. One approach that has recently received much attention is aptamer-based therapeutics. Aptamer technology has high target specificity and versatility, i.e., any viral proteins could potentially be targeted. Consequently, new aptamer-based therapeutics have the potential to lead a revolution in the development of anti-infective drugs. Additionally, aptamers can potentially bind any targets and any pathogen that is theoretically amenable to rapid targeting, making aptamers invaluable tools for treating a wide range of diseases. This review will provide a broad, comprehensive overview of viral therapies that use aptamers. The aptamer selection process will be described, followed by an explanation of the potential for treating virus infection by aptamers. Recent progress and prospective use of aptamers against a large variety of human viruses, such as HIV-1, HCV, HBV, SCoV, Rabies virus, HPV, HSV and influenza virus, with particular focus on clinical development of aptamers will also be described. Finally, we will discuss the challenges of advancing antiviral aptamer therapeutics and prospects for future success. </div>
</front>
</TEI>
<pubmed><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">24287493</PMID>
<DateCompleted><Year>2013</Year>
<Month>11</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised><Year>2018</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Electronic"><Journal><ISSN IssnType="Print">1424-8247</ISSN>
<JournalIssue CitedMedium="Print"><Volume>6</Volume>
<Issue>12</Issue>
<PubDate><Year>2013</Year>
<Month>Nov</Month>
<Day>25</Day>
</PubDate>
</JournalIssue>
<Title>Pharmaceuticals (Basel, Switzerland)</Title>
<ISOAbbreviation>Pharmaceuticals (Basel)</ISOAbbreviation>
</Journal>
<ArticleTitle>Aptamer-based therapeutics: new approaches to combat human viral diseases.</ArticleTitle>
<Pagination><MedlinePgn>1507-42</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.3390/ph6121507</ELocationID>
<Abstract><AbstractText>Viruses replicate inside the cells of an organism and continuously evolve to contend with an ever-changing environment. Many life-threatening diseases, such as AIDS, SARS, hepatitis and some cancers, are caused by viruses. Because viruses have small genome sizes and high mutability, there is currently a lack of and an urgent need for effective treatment for many viral pathogens. One approach that has recently received much attention is aptamer-based therapeutics. Aptamer technology has high target specificity and versatility, i.e., any viral proteins could potentially be targeted. Consequently, new aptamer-based therapeutics have the potential to lead a revolution in the development of anti-infective drugs. Additionally, aptamers can potentially bind any targets and any pathogen that is theoretically amenable to rapid targeting, making aptamers invaluable tools for treating a wide range of diseases. This review will provide a broad, comprehensive overview of viral therapies that use aptamers. The aptamer selection process will be described, followed by an explanation of the potential for treating virus infection by aptamers. Recent progress and prospective use of aptamers against a large variety of human viruses, such as HIV-1, HCV, HBV, SCoV, Rabies virus, HPV, HSV and influenza virus, with particular focus on clinical development of aptamers will also be described. Finally, we will discuss the challenges of advancing antiviral aptamer therapeutics and prospects for future success. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shum</LastName>
<ForeName>Ka-To</ForeName>
<Initials>KT</Initials>
<AffiliationInfo><Affiliation>Department of Molecular and Cellular Biology, Beckman Research Institute of City of Hope, 1500 East Duarte Rd, Duarte, CA 91010, USA. kshum@coh.org.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Zhou</LastName>
<ForeName>Jiehua</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y"><LastName>Rossi</LastName>
<ForeName>John J</ForeName>
<Initials>JJ</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y"><Grant><GrantID>R01 HL074704</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>U19 AI096111</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>R01 AI042552</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>R01 AI029329</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>U01 CA151648</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2013</Year>
<Month>11</Month>
<Day>25</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Switzerland</Country>
<MedlineTA>Pharmaceuticals (Basel)</MedlineTA>
<NlmUniqueID>101238453</NlmUniqueID>
<ISSNLinking>1424-8247</ISSNLinking>
</MedlineJournalInfo>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year>
<Month>10</Month>
<Day>17</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2013</Year>
<Month>11</Month>
<Day>12</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2013</Year>
<Month>11</Month>
<Day>15</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2013</Year>
<Month>11</Month>
<Day>30</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2013</Year>
<Month>11</Month>
<Day>30</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2013</Year>
<Month>11</Month>
<Day>30</Day>
<Hour>6</Hour>
<Minute>1</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">24287493</ArticleId>
<ArticleId IdType="pii">ph6121507</ArticleId>
<ArticleId IdType="doi">10.3390/ph6121507</ArticleId>
<ArticleId IdType="pmc">PMC3873675</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>J Biol Chem. 2011 Jan 28;286(4):2526-35</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21106536</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Rev Microbiol. 2003 Dec;1(3):209-18</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15035025</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Viral Hepat. 2013 Feb;20(2):103-12</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23301545</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Rev Drug Discov. 2013 Jun;12(6):447-64</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23722347</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Mol Ther. 2008 Aug;16(8):1481-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18461053</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochem Biophys Res Commun. 2008 Feb 15;366(3):738-44</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18082623</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Microbiol Mol Biol Rev. 2000 Mar;64(1):51-68</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10704474</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2013 Jun;87(12):7064-74</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23596299</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Biotechnol. 2006 Aug;24(8):1005-15</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16823371</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nucleic Acid Ther. 2012 Jun;22(3):162-76</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22554064</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Mol Ther. 2011 Dec;19(12):2228-38</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21952167</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Cell Biochem. 2002;85(4):663-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11968006</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Crit Rev Biochem Mol Biol. 2011 Dec;46(6):459-77</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21955150</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Rev Drug Discov. 2005 Oct;4(10):845-53</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16184083</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Anticancer Res. 1998 Nov-Dec;18(6B):4765-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9891554</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Antisense Nucleic Acid Drug Dev. 2002 Aug;12(4):265-74</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12238815</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Oligonucleotides. 2004;14(2):114-29</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15294075</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>AIDS. 1990 Jun;4(6):499-509</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2201316</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 1992 Mar;66(3):1476-83</Citation>
<ArticleIdList><ArticleId IdType="pubmed">1310759</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Eur J Pharm Sci. 2013 Jan 23;48(1-2):259-71</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23142634</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Rev Med Virol. 2007 May-Jun;17(3):205-15</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17295428</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Sci Transl Med. 2010 Jun 16;2(36):36ra43</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20555022</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2003 Dec;77(23):12692-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14610191</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 1994 Jun;68(6):3753-60</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8189513</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Mol Biol. 1994 Jan 7;235(1):237-47</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8289245</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Acta Virol. 2010;54(1):7-19</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20201609</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2012 Nov 8;367 (19):1814-20</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23075143</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2013 May 30;8(5):e64781</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23738000</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochem Biophys Res Commun. 2009 Aug 14;386(1):118-23</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19501043</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nucleic Acids Res. 2002 Sep 15;30(18):4001-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12235384</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Gen Virol. 2011 Jul;92(Pt 7):1493-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21471320</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nucleic Acid Ther. 2012 Aug;22(4):226-45</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22913595</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>RNA. 2005 Jun;11(6):873-84</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15923374</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>RNA. 2013 Jun;19(6):767-77</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23604636</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell. 1989 Aug 11;58(3):423-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2569361</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2012 Jun;86(12):6732-44</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22514343</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Chem Biol. 2008 Jul 21;15(7):644-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18635000</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Gen Virol. 2006 Mar;87(Pt 3):479-87</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16476969</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Sci Transl Med. 2011 Jan 19;3(66):66ra6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21248316</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Methods. 2011 Jun;54(2):204-14</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21320601</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochem Biophys Res Commun. 2011 Feb 18;405(3):417-21</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21238427</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Curr Drug Targets Inflamm Allergy. 2004 Mar;3(1):63-70</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15032642</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Curr Opin Mol Ther. 2010 Feb;12(1):107-14</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20140822</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Oligonucleotides. 2008 Jun;18(2):133-44</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18637731</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Biol Chem. 2000 Jun 16;275(24):18271-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10751399</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Antivir Ther. 2011;16(3):383-94</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21555821</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2005 Jan 18;102(3):634-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15637158</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Curr Med Chem. 2011;18(27):4117-25</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21838693</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Rev Drug Discov. 2006 Feb;5(2):123-32</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16518379</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int Immunopharmacol. 2012 Nov;14(3):341-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22771543</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 1990 May 3;345(6270):84-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2184372</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Mol Biol. 2002 Nov 22;324(2):195-203</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12441099</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 1990 Apr 5;344(6266):552-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">1690862</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochem Soc Trans. 2002 Apr;30(2):140-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12023841</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochem Biophys Res Commun. 2008 Feb 15;366(3):670-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18078808</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>EMBO J. 1998 Aug 3;17(15):4535-42</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9687519</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Expert Opin Pharmacother. 2005 Jul;6(8):1421-3</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16013991</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Chem. 2009 Apr;55(4):813-22</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19246617</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>RNA. 1999 Dec;5(12):1605-14</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10606271</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Antimicrob Agents Chemother. 2008 Jun;52(6):2097-110</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18347106</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Gene. 2000 Sep 19;255(2):235-44</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11024283</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Biol Chem. 2003 Oct 10;278(41):39578-82</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12917423</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2009 Mar 6;323(5919):1304-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19265012</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Front Biosci. 2006 Jan 01;11:89-112</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16146716</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochem Biophys Res Commun. 2002 Mar 8;291(4):925-31</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11866454</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Curr Opin Virol. 2012 Aug;2(4):459-66</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22658985</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Nanotechnol. 2010 Dec;5(12):833-42</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21102465</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Annu Rev Med. 2005;56:555-83</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15660527</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Chem Biol. 2012 Jan 27;19(1):60-71</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22284355</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Mol Ther. 2012 Dec;20(12):2304-14</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22948672</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 1999 Feb 16;96(4):1164-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9989993</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virol Sin. 2010 Feb;25(1):27-35</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20960281</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Pharm Res. 2008 Jan;25(1):72-86</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18074201</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Methods Mol Biol. 2011;721:67-75</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21431679</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nucleic Acids Res. 2006;34(16):4449-57</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16945960</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Genes Cells. 2000 May;5(5):371-88</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10886365</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochemistry. 1995 Jul 25;34(29):9599-610</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7542922</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2002 Jul;76(13):6545-57</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12050367</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Curr Med Chem. 2010;17(20):2101-40</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20423307</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Biol Chem. 2004 Nov 12;279(46):48410-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15358767</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Biochem. 2005 Mar;137(3):339-47</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15809335</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Oncogene. 2003 Sep 11;22(39):7871-81</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12970734</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Arch Virol. 2007;152(12):2137-57</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17851732</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ann Pharmacother. 1995 Jul-Aug;29(7-8):778-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8520096</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Mol Ther. 2011 Feb;19(2):386-94</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21063391</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell. 1991 Oct 4;67(1):169-78</Citation>
<ArticleIdList><ArticleId IdType="pubmed">1913815</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Farmaco. 1999 Jan-Feb;54(1-2):26-45</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10321027</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Biochem. 2003 Mar;133(3):263-70</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12761160</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Oncogene. 2008 Nov 24;27(55):7018-30</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19029942</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Microb Comp Genomics. 2000;5(3):129-51</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11252351</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BioDrugs. 2012 Dec 1;26(6):393-400</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23046156</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Pathol. 2010 Jun;63(6):480-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20360137</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2003 Apr 19;361(9366):1319-25</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12711465</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Circulation. 2007 Dec 4;116(23):2678-86</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18025536</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2005 Nov;79(21):13806-10</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16227301</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Pharmaceuticals (Basel). 2013 Mar 14;6(3):295-319</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23894227</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cancer Lett. 2002 Dec 15;188(1-2):15-24</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12406543</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 2011 Aug 03;476(7358):96-100</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21814282</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Gen Virol. 2009 Jul;90(Pt 7):1659-69</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19264618</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virus Res. 2013 May;173(2):398-403</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23333291</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell. 1989 Oct 20;59(2):273-82</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2478293</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2012 Jul 13;337(6091):183-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22798606</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Molecules. 2011 Jan 28;16(2):1271-96</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21278679</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2011 Jan;85(1):305-14</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20980522</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Rev Microbiol. 2012 Oct;10(10):681-92</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22961341</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Semin Liver Dis. 2012 May;32(2):167-76</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22760656</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>FASEB J. 2001 Mar;15(3):592-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11259377</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Arch Med Res. 2011 Feb;42(2):88-96</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21565620</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Gene Expr. 1996;5(4-5):217-28</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8723388</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ann Hematol. 1994 Sep;69(3):135-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8086508</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Mol Sci. 2012;13(3):3341-53</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22489154</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell. 1989 Oct 6;59(1):103-12</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2676191</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Liver Int. 2011 Jan;31 Suppl 1:111-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21205147</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Gene Ther. 2007 Jul;14(14):1057-64</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17607313</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virology. 2008 Nov 10;381(1):46-54</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18799178</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Biol Chem. 1999 Apr 30;274(18):12730-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10212256</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nucleic Acids Res. 2012 Dec;40(22):11777-83</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23042245</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Semin Liver Dis. 2000;20(1):1-16</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10895428</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 1984 Nov;52(2):615-23</Citation>
<ArticleIdList><ArticleId IdType="pubmed">6092683</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Curr Top Microbiol Immunol. 2005;292:45-56</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15981467</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>RNA. 2003 Sep;9(9):1029-33</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12923252</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Trends Microbiol. 2012 Jan;20(1):11-20</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22153752</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>RNA Biol. 2013 Feb;10(2):216-27</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23235494</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nucleic Acids Res. 2009 May;37(9):3094-109</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19304999</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cold Spring Harb Perspect Med. 2012 Apr;2(4):a007161</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22474613</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Hum Pathol. 1988 Jun;19(6):697-704</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2837431</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>AIDS. 1991 Jun;5(6):639-54</Citation>
<ArticleIdList><ArticleId IdType="pubmed">1883539</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>MBio. 2013 Apr 30;4(3):e00165-13</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23631916</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Trends Biochem Sci. 1993 Jul;18(7):255-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8212135</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nucleic Acids Res. 2005 Jan 28;33(2):683-92</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15681618</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Mol Ther Nucleic Acids. 2013 Feb 05;2:e71</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23385524</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>AIDS. 1996 Sep;10(10):1067-73</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8874622</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 1998 Jun 18;393(6686):648-59</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9641677</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Adv Virus Res. 2006;66:125-59</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16877060</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2002 Apr;76(8):3688-96</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11907208</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Gynecol Oncol. 2010 May;117(2 Suppl):S5-10</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20304221</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Microbiol. 2013 Jan;51(1):46-54</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23077124</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nucleic Acids Res. 2008 Dec;36(21):6739-51</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18948292</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Mol Cells. 2003 Dec 31;16(3):413-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14744035</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Silence. 2010 Feb 01;1(1):4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20226078</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Infect Disord Drug Targets. 2011 Jun;11(3):235-50</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21488834</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 1985 Jul 5;229(4708):69-73</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2990040</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Mol Ther. 2013 Jul;21(7):1378-89</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23629001</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Trends Microbiol. 1999 Apr;7(4):144-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10217828</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Trends Biochem Sci. 2005 May;30(5):231-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15896739</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Biochem. 2006 May;139(5):837-46</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16751591</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Curr Pharm Des. 2012;18(14):2014-26</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22376117</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Annu Rev Biochem. 2000;69:531-69</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10966468</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2012 May;86(9):4989-99</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22379083</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Biol Chem. 1998 Dec 25;273(52):34992-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9857031</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Drug Saf. 1993 Apr;8(4):312-20</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8481217</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Anal Biochem. 2005 Jul 15;342(2):312-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15913532</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochemistry. 1996 Oct 29;35(43):13762-71</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8901518</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nucleic Acids Res. 2013 Feb 1;41(3):1873-84</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23241386</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Oligonucleotides. 2011 Feb;21(1):1-10</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21182455</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Eur Rev Med Pharmacol Sci. 2012 May;16(5):667-71</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22774409</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochem Biophys Res Commun. 2002 May 10;293(3):924-31</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12051747</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Adv Exp Med Biol. 2011;719:81-103</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22125037</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Gene. 1993 Dec 27;137(1):33-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7506690</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Mol Cells. 2011 Dec;32(6):527-33</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22058017</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virology. 1997 Oct 27;237(2):270-82</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9356339</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2012;7(4):e36103</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22536456</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biol Chem. 2005 Feb;386(2):183-90</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15843163</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Handb Exp Pharmacol. 2009;(189):243-63</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19048203</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Curr Opin Virol. 2011 Dec;1(6):582-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22162985</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Curr Drug Targets Infect Disord. 2003 Dec;3(4):383-400</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14754437</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Mol Ther. 2002 Dec;6(6):770-82</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12498773</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Curr Opin Struct Biol. 1999 Feb;9(1):21-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10047577</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Methods Mol Biol. 2011;721:355-71</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21431697</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>DNA. 1984;3(1):23-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">6321120</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2003 Nov 22;362(9397):1733-45</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14643124</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochemistry. 2009 Jul 7;48(26):6278-84</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19496624</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell. 1982 Jun;29(2):403-15</Citation>
<ArticleIdList><ArticleId IdType="pubmed">6180831</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Med Chem. 1986 Sep;29(9):1561-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2427720</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nucleic Acid Ther. 2011 Dec;21(6):395-402</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22017542</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Methods. 2010 Oct;52(2):125-32</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20541015</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Trends Biochem Sci. 1998 Aug;23(8):297-301</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9757830</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochemistry. 2001 Aug 28;40(34):10087-94</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11513587</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochem Biophys Res Commun. 2004 Dec 17;325(3):670-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15541341</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Pharmaceuticals (Basel). 2013;6(1):85-107</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23667320</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell. 1992 Nov 13;71(4):663-70</Citation>
<ArticleIdList><ArticleId IdType="pubmed">1384989</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):13907-12</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11698656</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Chemistry. 2009;15(4):1036-42</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19053089</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Gen Virol. 2007 Feb;88(Pt 2):351-64</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17251551</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Rev Microbiol. 2006 Aug;4(8):588-96</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16845429</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>MBio. 2012 Nov 20;3(6):null</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23170002</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virus Genes. 2010 Feb;40(1):1-13</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19838783</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 1988 Nov 25;242(4882):1168-71</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2460924</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Mol Ther. 2013 Jan;21(1):192-200</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23164935</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2011;6(11):e27862</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22125633</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 1998 Jan 16;279(5349):384-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9430589</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int Rev Immunol. 2010 Dec;29(6):533-56</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20923332</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Antiviral Res. 1997 Dec;36(3):139-56</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9477115</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2013 Jun 13;368(24):2339-40</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23718151</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Methods Mol Biol. 2005;309:261-72</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15990406</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virol J. 2012 Feb 21;9:50</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22348291</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2013 Oct 1;110(40):15967-72</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24043813</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Methods. 2011 Jun;54(2):215-25</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21300154</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Nanomedicine. 2006;1(3):263-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17717967</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochem Biophys Res Commun. 2004 Aug 6;320(4):1181-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15249214</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Eur J Biochem. 2000 Jun;267(12):3685-94</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10848986</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochem Biophys Res Commun. 1995 Oct 4;215(1):160-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7575585</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nucleic Acids Res. 2003 Apr 1;31(7):1935-43</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12655010</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Vis Exp. 2011 Jun 23;(52):null</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21730942</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Philos Trans R Soc Lond B Biol Sci. 1993 Oct 29;342(1299):59-66</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7904348</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>ACS Nano. 2011 May 24;5(5):3405-18</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21604810</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Hepatol. 2013 Jul;59(1):52-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23542348</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virus Res. 2004 Dec;106(2):87-102</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15567490</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 1992 Aug 1;89(15):6988-92</Citation>
<ArticleIdList><ArticleId IdType="pubmed">1379730</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>AIDS Res Hum Retroviruses. 2007 May;23(5):699-708</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17530996</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Chembiochem. 2008 Dec 15;9(18):3037-45</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19031435</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochemistry. 2005 Aug 2;44(30):10388-95</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16042416</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 1990 Aug 30;346(6287):818-22</Citation>
<ArticleIdList><ArticleId IdType="pubmed">1697402</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>Californie</li>
</region>
</list>
<tree><noCountry><name sortKey="Rossi, John J" sort="Rossi, John J" uniqKey="Rossi J" first="John J" last="Rossi">John J. Rossi</name>
<name sortKey="Zhou, Jiehua" sort="Zhou, Jiehua" uniqKey="Zhou J" first="Jiehua" last="Zhou">Jiehua Zhou</name>
</noCountry>
<country name="États-Unis"><region name="Californie"><name sortKey="Shum, Ka To" sort="Shum, Ka To" uniqKey="Shum K" first="Ka-To" last="Shum">Ka-To Shum</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Checkpoint

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001226 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 001226 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    RBID
   |clé=     pubmed:24287493
   |texte=   Aptamer-based therapeutics: new approaches to combat human viral diseases.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i   -Sk "pubmed:24287493" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a SrasV1

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021

	Serveur d'exploration SRAS
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration SRAS

Aptamer-based therapeutics: new approaches to combat human viral diseases.

Aptamer-based therapeutics: new approaches to combat human viral diseases.

Source :

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki